Skip to main content

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies

Immune humanized platforms are ideal for lead optimization and safety data sets supporting Investigational New Drug (IND) applications. In this webinar, Brian Soper, Ph.D. presents preclinical data demonstrating:

  • Monoclonal antibody-based human immune modulation
  • Donor-specific differences in bispecific antibody-mediated tumor efficacy and cytokine release
  • CAR T cell-mediated tumor efficacy and safety